Melanocortin-4 Receptor Binding Compounds and Methods of use thereof

Details for Australian Patent Application No. 2004202804 (hide)

International Classifications

Event Publications

8 July 2004 Complete Application Filed

22 July 2004 Application Open to Public Inspection

Published as AU-B-2004202804

24 February 2005 Assignment before Grant

Millenium Pharmaceuticals, Inc The application has been assigned to Gene Logic Inc.

13 March 2008 Alteration of Name

The name of the applicant has been altered to Ore Pharmaceuticals Inc.

29 January 2009 Application Accepted

Published as AU-B-2004202804

28 May 2009 Standard Patent Sealed

4 March 2010 Application Lapsed, Refused Or Withdrawn, Patent Ceased or Expired

This patent ceased under section 143(a), or Expired. Note that applications or patents shown as lapsed or ceased may be restored at a later date.

Legal

The information provided by the Site not in the nature of legal or other professional advice. The information provided by the Site is derived from third parties and may contain errors. You must make your own enquiries and seek independent advice from the relevant industry professionals before acting or relying on any information contained herein. Check the above data against the Australian Patent Office AUSPAT database.